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Smeele KM, Eerbeek O, Schaart G, Koeman A, Bezemer R,
Nelson JK, Ince C, Nederlof R, Boek M, Laakso M, de Haan A, Drost
MR, Hollmann MW, Zuurbier CJ. Reduced hexokinase II impairs
muscle function 2 wk after ischemia-reperfusion through increased cell
necrosis and fibrosis. J Appl Physiol 113: 608–618, 2012. First published
June 21, 2012; doi:10.1152/japplphysiol.01494.2011.—We previously
demonstrated that hexokinase (HK) II plays a key role in the patho-
physiology of ischemia-reperfusion (I/R) injury of the heart (Smeele
et al. Circ Res 108: 1165–1169, 2011; Wu et al. Circ Res 108: 60–69,
2011). However, it is unknown whether HKII also plays a key role in
I/R injury and healing thereafter in skeletal muscle, and if so, through
which mechanisms. We used male wild-type (WT) and heterozygous
HKII knockout mice (HKII/) and performed in vivo unilateral
skeletal muscle I/R, executed by 90 min hindlimb occlusion using
orthodontic rubber bands followed by 1 h, 1 day, or 14 days reper-
fusion. The contralateral (CON) limb was used as internal control. No
difference was observed in muscle glycogen turnover between geno-
types at 1 h reperfusion. At 1 day reperfusion, the model resulted in
36% initial cell necrosis in WT gastrocnemius medialis (GM) muscle
that was doubled (76% cell necrosis) in the HKII/ mice. I/R-induced
apoptosis (29%) was similar between genotypes. HKII reduction elimi-
nated I/R-induced mitochondrial Bax translocation and oxidative stress at
1 day reperfusion. At 14 days recovery, the tetanic force deficit of the
reperfused GM (relative to control GM) was 35% for WT, which was
doubled (70%) in HKII/ mice, mirroring the initial damage ob-
served for these muscles. I/R increased muscle fatigue resistance
equally in GM of both genotypes. The number of regenerating fibers
in WT muscle (17%) was also approximately doubled in HKII/ I/R
muscle (44%), thus again mirroring the increased cell death in
HKII/ mice at day 1 and suggesting that HKII does not signifi-
cantly affect muscle regeneration capacity. Reduced HKII was also
associated with doubling of I/R-induced fibrosis. In conclusion, re-
duced muscle HKII protein content results in impaired muscle func-
tionality during recovery from I/R. The impaired recovery seems to be
mainly a result of a greater susceptibility of HKII/ mice to the
initial I/R-induced necrosis (not apoptosis), and not a HKII-related
deficiency in muscle regeneration.
fatigue; fibrosis; healing; regeneration; skeletal muscle
SKELETAL MUSCLE ISCHEMIA-REPERFUSION (I/R) frequently occurs in
many acute (surgical intervention, circulatory shock, trauma) or
chronic (decubitus, diabetes, obstructive vascular disease) clinical
situations, resulting in muscle dysfunction and myocyte death,
which in turn contributes to increased morbidity and mortality
even when limb circulation is restored. Elucidating and subse-
quent targeting of underlying cellular mechanisms may help
alleviate the burden of skeletal muscle I/R. The present study
examines a possible role of the glycolytic enzyme hexokinase
(HK) II in skeletal muscle I/R injury.
Earlier cellular studies have demonstrated that the glycolytic
enzyme HKI or HKII may have strong protective effects against
stress-induced cell death (30). In addition, the increased expres-
sion of HK in malignant tumors is thought to contribute to the
immortalization of cancer cells (25). Recently, we have demon-
strated that HKII also plays an important role in the degree of
acute injury and remodeling following I/R in the heart (33, 38). In
the heart, HKI and HKII are approximate equally distributed.
However, in skeletal muscle, HKII is the predominant HK iso-
form present (34), suggesting an even more prominent role of
HKII in skeletal muscle I/R injury compared with the heart.
Indeed, we found that reduced HKII resulted in cell death in a
noninjurious I/R model of intact mouse skeletal muscle (32).
However, in this preliminary study, I/R injury was evaluated after
a short period of ischemia (60 min) and reperfusion (90 min) only,
resulting in minor I/R injury. Moreover, skeletal muscle has the
capacity to regenerate and therefore recover from injury, in con-
trast to the very limited regenerative capacity of the heart. To our
knowledge, no information exists concerning a possible role of
HK in severe skeletal muscle I/R injury and regeneration. There-
fore, in the present study, an extended period of ischemia (90 min)
and prolonged periods of reperfusion (1 day and 14 days) were
examined to investigate the effect of HKII on severe muscle I/R
injury and subsequent muscle regeneration.
The mechanisms through which HK offers protection are
unresolved but probably pertain to its binding to the mitochon-
dria (30, 31, 40). It has been suggested that mitochondrial HK
prevents apoptosis through inhibition of mitochondrial binding
of the proapoptotic protein Bax (29), although Majewski et al.
(24) demonstrated that HK protective effects were still present
in Bax-deficient cells. We were also unable to confirm a role
for mitochondrial Bax in causing increased I/R injury in
HKII-reduced hearts (33). Other mechanisms through which
mitochondrial HK may alleviate injury relates to inhibition of
necrosis and/or attenuation of oxidative stress through regula-
tion of mitochondrial ATP/ADP exchange (9).
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In the present study, we addressed whether HKII reduction
affects 1) acute, severe I/R injury of skeletal muscle, with a
possible role for necrosis, apoptosis, glycogen turnover, mito-
chondrial Bax, and oxidative stress; and 2) structural and
functional healing through regeneration of postischemic, rep-
erfused skeletal muscle tissue. A recently developed, noninva-
sive approach of the I/R intervention was chosen (7, 26), using
orthodontic rubber bands to obtain complete hindlimb ischemia
and reperfusion.
METHODS
All procedures were in accordance with the guidelines of and ap-
proved by the Animal Ethical Committee of the University of Amsterdam
and conform to National Institutes of Health guidelines.
Animals
C57BL/6J mice containing a partial deletion of the HKII gene
(HKII/) (17), were in-house bred under standard housing condi-
tions (12:12-h light-dark cycle; water and food given ad libitum) and
fed Purina Laboratory Rodent Diet 5001 standard chow (PURINA;
PMI Nutrition International). These animals were shown to have
reduced HK activity and HKII isoform levels in both heart and
gastrocnemius medialis (GM) skeletal muscle (32, 34), without effect
on HKI protein levels. Genotypes were determined by standard PCR
technique after extraction of DNA from toe tissue after weaning, and
verified from ear tissue analysis after experiment termination. Male
mice of 3–4 mo were used.
Experimental Procedures
Prior to performing the actual experiments, we performed pilot
experiments in wild-type (WT) animals to determine the amount of
injury created with increasing ischemic periods of 1, 1.5, or 2 h
followed by 24 h reperfusion (n  3–5 per group). Injury was
determined by the amount of released lactate dehydrogenase (LDH)
enzyme from I/R muscle and calculated as the ratio of LDH in the I/R
and contralateral control muscle. Subsequently, WT and HKII/
mice were studied in four different experiments: group A, 90 min
ischemia followed by 24 h reperfusion (n  6–8 per group); and
group B, 90 min ischemia followed by 14 days reperfusion (n  5–7
per group). Additionally, to examine a possible role of glycogen
among the genotypes, glycogen content of GM was determined in two
separate groups: group C, in I/R GM of WT animals immediately after
ischemia (n  6); and group D, in control and I/R GM of WT (n 
6) and HKII/ animals (n  9) at 1 h reperfusion following 90 min
of unilateral ischemia. For group D muscles, caspase-3/7 activity was
also determined. At the end of each experiment, all animals were
killed using cervical dislocation during a surgical plane of anesthesia.
Validation of ischemia and reperfusion. A laser speckle imaging
(LSI) technique was used to assess limb perfusion (6, 11) during
ischemia and reperfusion in separate experiments using WT animals
(n  3). For LSI measurements, a commercially available system was
used (Moor Instruments). A 785-nm class 1 laser diode was employed
for illumination of the tissue, and light directly reflected by the tissue
surface was blocked by a tunable polarizer in front of the lens system.
Laser speckle images were captured using a 576  768 pixels
grayscale CCD camera at a frame rate of 25 Hz and converted to
pseudo-color images, where the level of perfusion was scaled from
blue (low perfusion) to red (high perfusion). I/R was performed in the
exact manner and duration as described below. The LSI was posi-
tioned 50 cm above the animal and focused such that both hindlimbs
could be monitored simultaneously. Laser speckle images of both
GMs were obtained at baseline, ischemia, and reperfusion. The per-
fusion of the I/R muscle was calculated relative to the perfusion of the
contralateral muscle and normalized to baseline values.
Ischemia and reperfusion procedure. In vivo I/R was performed
slightly modified from the method described by Crawford et al. (7).
Briefly, induction of anesthesia was performed with an intraperitoneal
injection of 80 mg/kg pentobarbital sodium and was followed by a
subcutaneous injection of 1 ml saline for fluid support. Body temper-
ature of each mouse was monitored continuously with a rectal ther-
mometer and maintained at 37°C throughout the complete procedure
using heating pads. Ischemia for 90 min was applied to one hindlimb
using two orthodontic rubber bands (no. 110, 3.2 mm, Latex O-Rings;
Miltex Instruments) placed together at the most proximal side of the
thigh as close to the pelvic as possible using a McGivney Haemor-
rhoidal Ligator (Miltex Instruments). During ischemia anesthesia was
maintained by intraperitoneal injection of 20 mg/kg pentobarbital
sodium at 30 min and 75 min after induction. Additionally, 10 mg/kg
pentobarbital sodium was injected 100 min after induction (i.e., just
before reperfusion) to prevent the mice from moving at the first,
crucial minutes of reperfusion. Reperfusion was created by cutting the
rubber bands and visually confirmed by the color change of the paw
from blue to red. Throughout the I/R procedure the contralateral
(CON) hindlimb was left untreated to serve as internal control.
Animals returned to the (nonheated) cage after 1 h reperfusion.
Animals of experimental group A were anesthetized after 1 day
reperfusion with ketamine (125 mg/kg), medetomidine (0.2 mg/kg),
and atropine (0.5 mg/kg) (41) and GM and gastrocnemius lateralis
(GL) of both hindlimbs excised for further analysis. This procedure
was also performed for animals of group B after 14 days reperfusion
with the exception that force measurements (described below) were
performed prior to tissue excision.
Force measurements. Preparation and force measurements were iden-
tical as previously described (32). In brief, animals were ventilated
mechanically after tracheotomy. To perform in situ stimulation, the
medial head of the gastrocnemius was prepared free from surrounding
tissue, leaving the origin on the femur and blood supply intact. Distally,
the Achilles tendon was cut and attached through a metal hook to a force
transducer (42). The muscle was stimulated via the severed sciatic nerve,
with temperature kept at 37°C throughout the experiment. Muscle opti-
mal length using twitch contractions was determined (10), and maximum
twitch and tetanic force was measured. Twitch and tetanic forces were
measured as millinewtons and normalized to GM wet muscle mass
(Table 1). Both were used as index of functional recovery of I/R relative
to CON GM performance. Finally, muscle fatigue was assayed by
application of 30 repetitive tetani (stimulation frequency 150 Hz, stimu-
lation duration 50 ms, pulse width 40 s, one contraction every 250 ms)
as described previously (19).
GM cryopreservation and homogenization. CON and I/R GMs
from group A and group B were excised from the anesthetized animals
and weighed. Each GM was cut in half over the length-axis. One part
was immediately cryopreserved for immunohistological determina-
tion by embedding in Tissue-Tek (Sakura Finetek) and quickly frozen
Table 1. Body weight and GM muscle mass of WT and
HKII/ animals at 1 day reperfusion (n  8 each group)
and 14 days reperfusion (n  7 each group)
WT HKII/
CON I/R CON I/R
1 Day reperfusion
Mass, mg 49  3 56  2† 49  2 58  3†
Body weight, g 27.8  0.8 27.4  0.6
14 Days reperfusion
GM wet mass, mg 47  2 27  2† 43  2 25  1†
Body weight, g 24.9  0.6 25.1  0.7
Values are means  SE. GM, gastrocnemius medialis; WT, wild-type;
HKII/, heterozygous hexokinase II knockout; CON, contralateral control
limb; I/R, ischemia-reperfusion. †P  0.05, I/R vs. CON, same genotype.
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in liquid nitrogen-prechilled isopentane (Sigma-Aldrich) and directly
stored at 80°C until further analysis. The second GM part was
directly homogenized in 0.8 ml ice-cold isolation buffer containing (in
mM) 250 sucrose, 20 HEPES buffer (pH 7.4), 10 KCl, 1.5 MgCl2, 1
EDTA, 0.1 PMSF, as well as 5 g/ml leupeptin, 5 g/ml aprotinin,
and 1 g/ml pepstatin A. Half of the homogenate was centrifuged at
10,000 g for 10 min. The pellet contained the crude mitochondrial
fraction and the supernatant the cytosolic fraction. The other half of
homogenate was determined as whole cell fraction. Samples were di-
rectly stored at 80°C until further analysis. Muscles from groups C and
D were excised, immediately frozen in liquid nitrogen, and stored at
80°C until further analysis for glycogen content and caspase-3/7 activ-
ity. Mice were subsequently killed by cervical dislocation.
Edema measurement. After excision of GMs, the gastrocnemius late-
ralis (GL) was excised for group B, weighed (to obtain the GL wet
weight), and dried in a stove at 60°C for 48 h and weighed again to obtain
GL dry weight. Edema was calculated as ratio of wet to dry GL weight.
Postexperimental Analysis
Immunohistochemistry. For the immunofluorescence and the
TUNEL-reaction we used 5-m-thick serial tissue specimens. The spec-
imen from the I/R and CON GM were placed on the same glass slide per
experiment. Necrotic cells were detected by intracellular caveolin stain-
ing, based on the premise that loss of plasma membrane integrity is a
primary characteristic of necrosis. Apoptotic cells were detected by the
TUNEL assay (In situ Cell Death Detection Kit, POD, Roche), based on
the premise that DNA fragmentation is a primary characteristic of
apoptosis (22). For counting the amount of necrotic cells (group A, 1 day
reperfusion) and analysis of regeneration by measuring cell surface and
counting number of cells with centralized nuclei (group B, 14 days
reperfusion), GM slices were incubated with anti-caveolin (red; CAV;
1:100; BD Biosciences), anti-laminin (green; LAM; 1:50; Sigma), and
anti-DAPI (blue; 300 nM; Invitrogen), staining for necrotic cells, cell
membrane, and nuclei, respectively. Cells were counted as necrotic when
the intracellular surface stained for caveolin. Number of necrotic cells and
number of cells with centralized nuclei were counted by hand and
analyzed as ratio to the total cell number counted in each picture. The
number of apoptotic cells equaled the number of myocyte-related
TUNEL-positive nuclei divided by total number of myocyte-related
nuclei [ nuclei (DAPI-staining) close to cell membrane (LAM stain-
ing)]. Total cell surface was determined by drawing the borders of the
laminin-stained cells by hand, hereby eliminating (nonstained) intracel-
lular space, followed by software-determined calculation of the selected
area. Subsequently, mean cell surface was determined by dividing total
cell surface by total number of cells counted in each picture. Other GM
tissue slices were incubated with anti-CD31 (red; 1:100; BD Biosciences)
together with anti-laminin (blue; 1:50; Sigma) to stain for capillaries and
cell membrane, respectively. Angiogenesis in the GM after 14 days
reperfusion was determined by counting the number of CD31-stained
capillaries within the LAM-stained myocytes in each image. The number
of capillaries was normalized to total cell area, whose borders were drawn
by hand, and the area was measured automated and shown as square
millimeters. Fibrosis, the amount of intercellular collagen formed, was
analyzed by measuring the total collagen surface (red) and total cell
surface (pink) in each image after performing a Sirius red staining.
All above-mentioned analyses were performed in a blinded fashion,
both to genotype and to condition. Each parameter was determined in
three to five images per GM, with each image analyzed two to three
times. All images were 20 magnifications, and analysis was performed
using Lucia G/F imaging analysis software (Laboratory Imagin, CZ).
Mitochondrial Bax amount. The pellet of the crude mitochondrial
fraction from experimental group A (1 day reperfusion) was resus-
pended in isolation buffer and incubated for 1 h with 2% CHAPS to
contain Bax oligomers formed due to I/R (1). For tissue lysation the
samples were sonicated and debris was removed by centrifugation at
100,000 g for 30 min. The supernatant, consisting of the solubilized
mitochondrial fraction, was incubated with 1 mM disuccinimidyl
suberate (DSS, Thermo Scientific) dissolved in DMSO for cross-
linking of Bax complexes. The chemical reaction was stopped by
addition of loading buffer containing mercaptoethanol and analyzed
for total (monomer and oligomer) mitochondrial Bax amount by
Western blotting. Fifteen micrograms of protein per slot was loaded
on a 10% SDS-polyacrylamide denaturing gel. PVDF membranes
were incubated with anti-Bax (1:1,000; BD Biosciences) and anti-
VDAC (1:10,000; Calbiochem) as loading control, followed by horse-
radish peroxidase-conjugated secondary goat anti-mouse antibodies
(1:10,000; Jackson ImmunoResearch) and anti-biotin (1:2,000; Cell
Signaling). Immunoreactive bands were visualized by chemilumines-
cence on X-ray film (Hyperfilm ECL, Amersham) using enhanced
chemiluminescence solution (Santa Cruz). For quantification a Kodak
Image Station 440CF (Eastman Kodak) was used. Each sample was
analyzed in duplicate.
Oxidative stress. Homogenized I/R and CON GM tissue samples of
experimental group A (1 day reperfusion) were analyzed. Oxidative
stress was determined by analyzing the degree of protein carbonyla-
tion in the supernatant of whole cell homogenate, obtained after 0.5%
Triton X-100 treatment and centrifugation at 12,000 g for 10 min. The
method uses derivatization of protein carbonyl groups with 2,4-
dinitrophenyl hydrazine (DNPH) producing hydrazone, which is de-
tected spectrophotometrically (Protein Carbonyl Assay kit; Cayman
Chemical). Values were normalized to sample protein concentration
(Bradford assay).
Enzyme activity measurements. GM whole cell homogenate of
experimental group B was treated with 0.5% Triton X-100 to solubi-
lize hexokinase (21), followed by centrifugation (12,000 g; 1 min) to
pellet crude undissolved remnants. All enzyme activities were spec-
trophotometrically determined in the resulting supernatant at 25°C.
HK and citrate synthase (CS) activity was measured as reported
previously (16). HK activity was normalized to CS activity. Lactate
dehydrogenase (LDH), as index of necrosis used in the pilot experi-
ments, was measured using KH2PO4 buffer, NADH, and pyruvate and
normalized to sample protein (Bradford assay) concentration.
Glycogen amount. Frozen muscles were grinded into powder in
liquid nitrogen, and a small part of the powder was used for glycogen
determination, the other part for caspase 3/7 activity analysis. Glyco-
gen was enzymatically converted to glucose using amyloglucosidase
(Roche Diagnostics). Glucose was determined by a two-step enzy-
matic method using HK and glucose-6-phosphate dehydrogenase
(both Roche Diagnostics) as described in Ref. 3. Liquid handling was
performed by a Freedom EVO 100 robot (Tecan) and formation of
NADPH was measured fluorometrically using an Infinite plate reader
(Tecan). Values were normalized to sample protein concentration
(Bradford assay).
Caspase-3/7 activity assay. Part of the grinded GM was dissolved
in 0.6 ml ice-cold isolation buffer containing (in mM) 250 sucrose, 20
HEPES buffer (pH 7.4), 10 KCl, 1.5 MgCl2, 1 EDTA, 0.1 PMSF, as
well as 5 g/ml leupeptin, 5 g/ml aprotinin, 1 g/ml pepstatin A,
and 0.5% CHAPS (Sigma-Aldrich). After 5 min incubation at room
temperature, each sample was sonicated for 5 s and subsequently
centrifuged at 12,000 g for 10 min at 4°C. The supernatant was
transferred into a new vial and stored at 80°C until further analysis.
Caspase-3/7 activity was assessed in the supernatant with the
Caspase-Glo 3/7 assay kit (G8090, Promega, Madison, WI). Seventy-
five microliters of supernatant was diluted in 75-l assay buffer, and
luminescence was detected according to the manufacturer’s protocol.
Values were normalized to sample protein concentration (Bradford).
Statistics
Values are presented as means  SE. Differences between WT and
HKII/ groups were analyzed by a two-way ANOVA (main effects:
genotype and I/R treatment; interaction effect: genotype  I/R-
treatment) for repeated measurements followed by contrast compari-
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son (SPSS version 18). Differences were considered statistically
significant at P  0.05.
RESULTS
Model Characteristics
Optimalization of ischemic model. The degree of I/R damage
is critically dependent on the duration of ischemia. Therefore,
we performed pilot experiments to determine the optimal
duration of ischemia at which damage would be severe enough,
but still be amenable to decreases or increases. Ischemia was
applied for 1, 1.5, or 2 h and followed by 24 h reperfusion.
LDH measurements, as parameter of necrosis and therefore
muscle damage, showed that with each 30-min prolongation of
ischemia the degree of damage was increased proportionally
(Fig. 1A). The optimal duration of ischemia to test our hypoth-
eses appeared to be 90 min, resulting in 60% muscle damage
as measured by LDH leakage from the I/R GM muscle.
Muscle perfusion. To validate successful ischemia and reper-
fusion in this noninvasive I/R model, we monitored relative
muscle perfusion simultaneously in both hindlimbs using laser
speckle imaging. Figure 1B (middle panel) clearly shows imme-
diate, near-complete occlusion of limb perfusion upon tight ap-
plication of two rubber bands. Removal of the occlusion imme-
diately restored blood flow in the whole limb (Fig. 1B, right
panel). Applying I/R to one hindlimb appeared to be without
influence on muscle perfusion in the contralateral, control
hindlimb (Fig. 1B). Hyperemia was clearly detectable during the
first minutes of reperfusion, after which perfusion returned close
to normal from 5 min reperfusion onward (Fig. 1C).
Thus the method of I/R application that was used appeared to
be nondamaging to the limb vasculature and resulted in severe
ischemic injury when applied for 90 min and successful reperfu-
sion of the hindlimb in vivo.
One Hour Reperfusion
Glycogen content. No differences were observed between
glycogen content in control muscles between genotypes (Fig. 2A).
Fig. 1. Model characterization measurements. A: cytosolic lactate dehydroge-
nase (LDH) activity measurements as parameter for cellular injury, shown as
percentage of ischemia-reperfusion (I/R) compared with contralateral (CON)
limb values as measured in pilot experiments with 1, 1.5, or 2 h ischemia
followed by 1 day reperfusion. Muscle perfusion was measured using using
laser speckle imaging. B: images of the same mouse of both hindlimbs at the
moment of baseline (BL), 1 min ischemia (I-01), and 1 min reperfusion (R-01).
Left limb is I/R and right limb is CON limb. Degree of perfusion is visualized
by color: blue  none to low, yellow  medium, and red  high perfusion.
C: muscle perfusion during I/R (n  3), normalized to CON limb and relative
to BL values. Values are given as means  SE.
Fig. 2. Glycogen content and caspase-3/7 activity after ischemia followed by
1 h reperfusion. Glycogen was measured in control and I/R muscle tissue of
wild-type (WT) and heterozygous hexokinase II knockout (HKII/) mice (A).
Caspase-3/7 activity was determined in control and I/R muscle tissue of WT
and HKII/ mice (B). Values are given as means  SE. #P  0.05 vs. CON
group of same genotype.
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At 1 h reperfusion, there was a clear trend of diminished glycogen
content in I/R muscles relative to control muscles, indicating
glycogen breakdown during the ischemic period. However, no
differences in I/R-induced glycogen breakdown between geno-
types were detected. In a second series of experiments we mea-
sured glycogen content in I/R wild-type muscle immediately after
ischemia, thus without reperfusion. The measured amount of
glycogen (17.4  3.2 nmol/mg protein) in ischemia-only muscle
is much lower than the glycogen content of 1 h reperfused
muscles (79.7  28 nmol/mg protein), indicating that 1 h reper-
fusion does substantially recover muscle glycogen content.
Caspase-3/7 activity. Caspase activity was measured in
control and I/R muscle of both genotypes at 1 h reperfusion
(Fig. 2B). No differences in caspase activity in control muscles
between WT and HKII/ mice were detected. Surprisingly,
caspase activity in I/R muscle of WT was significantly de-
creased compared with control muscle. However, no differ-
ences in I/R-induced alterations in muscle caspase activity
between WT and HKII/ mice were observed.
Twenty-Four Hours Reperfusion
Cellular damage. I/R-induced muscle necrosis and apoptosis
were clearly present after 24 h reperfusion, as assessed using
histological analysis. As the representative images in Fig. 3A
show, CON myocytes of both genotypes were unaffected by
the I/R procedure performed with the opposite limb as they had
retained their normal morphological features—polygonal shape
and tightly aligned—and did not stain intracellularly for caveolin.
In I/R GM of WT animals 36% of myocytes were necrotic (Fig.
Fig. 3. Tissue damage after ischemia followed
by 1 day reperfusion. Cellular necrosis and
apoptosis were histologically evaluated using
caveolin (red; CAV), laminin (green; LAM), and
DAPI (blue) for necrosis (A) and using laminin
(red; LAM), DAPI (blue), and TUNEL (green)
for apoptosis (C) staining, respectively. The
number of necrotic cells (B) and apoptotic cells
(D) are shown relative to total cell count in each
image. Increased edema (E) was found in I/R
muscle tissue compared with CON as measured
by gastrocnemius lateralis (GL) wet-to-dry
weight ratio. Values are given as means  SE.
*P  0.05 vs. WT group. #P  0.05 vs. CON
group of same genotype.
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3B) and were morphologically mostly rounded and separated
from each other (Fig. 3A). The number of necrotic myocytes
was significantly increased to 76% in HKII/ animals (Fig.
3B). Apoptotic cells were barely detectable in control muscle
of both genotypes (Fig. 3, C and D). I/R induced an increase in
apoptotic cells to 26  3% (WT) and 33  6% (HKII/)
muscle. However, the I/R-induced increase in apoptosis was
not significantly different between WT and HKII/ muscle.
I/R-induced edema was 50% for both WT and HKII/
animals (Fig. 3E).
I/R-induced mitochondrial Bax and oxidative stress. Since
HKII may exert its cellular protective role by directly influ-
encing the amount of mitochondrial bound proapoptotic pro-
tein Bax, due to competition for the same mitochondrial
binding site (29), we investigated the total amount of mito-
chondrial Bax (Fig. 4A). Mitochondrial Bax more than doubled
in WT animals upon I/R, indicating that skeletal muscle I/R is
indeed associated with a translocation of Bax to mitochondria.
Remarkably, this effect of I/R on mitochondrial Bax was
absent in HKII/ animals. No differences were observed in
amount of mitochondrial Bax in CON GM between WT and
HKII/ animals.
To study a possible effect of HKII on oxidative stress due to
I/R, the degree of protein carbonylation in the whole cell
homogenate of the GM was studied. As Fig. 4B shows, in-
creases in protein carbonylation in the I/R muscle were ob-
served for WT animals, indicating that skeletal muscle I/R is
indeed associated with elevated oxidative stress. Surprisingly,
I/R was not associated with increased carbonylation in the GM
of the HKII/, whereas basal levels of carbonylation in the
CON muscle were similar between genotypes. The data there-
fore indicate that the increased injury following I/R in the
HKII/ muscle cannot be explained through increases in
mitochondrial Bax or oxidative stress.
Fourteen Days Reperfusion
As a result of the finding that HKII reduction does severely
increase the amount of cells injured due to the I/R procedure,
we investigated whether HKII reduction would also influence
the subsequent muscle repair processes. GM tissue was studied
after 90 min ischemia and a subsequent period of 14 days
reperfusion, a moment at which all injured cells have been
eliminated and different processes of skeletal muscle regener-
ation are in progress (20, 27).
Mitochondrial capacity and HK activity. To examine whether
I/R and regeneration affected mitochondrial capacity and total HK
activity relative to mitochondrial content, and to what extent this
was affected by the deletion of one HKII allele, CS and HK
activity were determined. CS was not different between genotypes
and was unaffected by I/R and regeneration (Fig. 5A). Contrast-
ingly, I/R and regeneration resulted in large increases in HK
activity relative to CS activity. This increase was unaffected by
Fig. 5. Mitochondrial capacity and HK activity measured in WT and HKII/
whole cell homogenate of ischemia-reperfusion treated (I/R) and contralateral
(CON) GM after 14 days reperfusion. A: citrate synthase (CS) activity values
normalized to protein content as parameter of mitochondrial capacity. B: HK
activity shown as ratio to CS enzyme activity. Values are given as means 
SE. *P  0.05 vs. corresponding WT group. #P  0.05 vs. CON group of
same genotype.
Fig. 4. Proapoptotic Bax and oxidative stress were investigated at 1 day
reperfusion. A: mitochondrial Bax normalized to VDAC content of I/R and
CON GM muscles of WT and HKII/. B: protein carbonylation content of
WT and HKII/ GM and shown as carbonyl content normalized to protein
content. Values are given as means  SE. #P  0.05 vs. corresponding CON
group. $P  0.05 for interaction effect (I/R treatment effect in WT vs. that in
HKII/).
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the ablation of one HKII allele (Fig. 5B). The data indicate that the
response of skeletal muscle to a severe ischemic period followed
by 14 days of healing contains a large increase of the HK enzyme
without alterations in mitochondrial capacity. Ablation of one
HKII allele resulted in 50% reduction in total HK activity
compared with WT, indicating that HK activity in GM is predom-
inantly HKII activity.
Functional recovery and fatigue resistance. Both twitch (8.2 
0.6 vs. 10.4  0.6 mN/mg) and tetanic force production (31.5 
2.1 vs. 34.0  2.0 mN/mg) were similar for control GM between
WT and HKII/ mice, respectively. However, HKII reduction
diminished both twitch (Fig. 6A) and tetanus (Fig. 6B) force
recovery following ischemia and 14 days healing: functional
recovery in HKII/ GM was 50% of the recovery observed for
WT GM. Resistance to fatigue was investigated by measuring the
developed force upon application of 30 repetitive tetani and
relating the value measured for each tetanus to the value of the
first tetanus during reperfusion (Fig. 6C). The high-intensity
fatigue protocol showed a strong decrease in force in the control
GM, which was not significantly different between WT and
HKII/. I/R and 14 days healing resulted in increased fatigue
resistance of the GM of both genotypes. The I/R-induced increase
in fatigue resistance was not affected by ablation of one HKII
allele.
Muscle regeneration. Muscle regeneration is characterized by
the presence of immature fibers recognized as centronucleated
fibers of small size. Representative images in Fig. 7A clearly
demonstrate the smaller (52 to 55%) cell size and increased
incidence of centronucleated cells following I/R for both WT and
HKII/ mice. No centronucleated myocytes were found in CON
muscles of both genotypes. Surprisingly, cell size in the HKII/
CON muscle was significantly smaller (14%) than that in the
WT CON muscle (Fig. 7B), indicating that HKII may be a
determinant of myocyte cell size. I/R reduced cell size to a large
extent in our model; the reduction was not different between WT
and HKII/ mice. In contrast, the number of centronucleated
fibers in the I/R muscle was significantly larger for HKII/ GM
(44%) compared with that in the WT GM (17%; Fig. 7C).
Angiogenesis. Capillaries were detected using the endothe-
lial marker CD31 (Fig. 8A). No significant differences were
observed in capillary density of CON muscle between WT and
HKII/ mice. I/R and 14 days healing resulted in increased
capillary density of the GM; this increase, however, was not
affected by the partial deletion of the HKII allele (Fig. 8B). The
data indicate therefore that HKII does not play a critical role in
skeletal muscle angiogenesis following I/R.
Fibrosis. The degree of fibrosis that developed in reaction to
the I/R intervention was investigated by measuring the amount
of interstitial collagen. In both Fig. 9A (representative images)
and 9B, it is shown that fibrosis amounted to 1.3% and 0.9% of
muscle area in control GM of WT and HKII/ mice, respec-
tively. I/R increased fibrosis to 4.5% in WT mice and to 6.8%
in HKII/ mice; the increase in the HKII/ mice was
significantly larger compared with that in the WT mice. The
almost doubling of I/R-induced fibrosis at 14 days healing in
the HKII/ mice mirrors the doubling of acute I/R-induced
cell necrosis in these muscles (Fig. 3B). This indicates that
HKII probably does not play a major role in the development
of fibrosis during muscle healing.
DISCUSSION
The major findings of this study are that reductions in HKII
in a skeletal muscle model of I/R result in 1) increased myocyte
cell necrosis at day 1 of reperfusion, without alterations in
I/R-induced glycogen turnover or apoptosis or increases in
mitochondrial Bax and oxidative stress; 2) reduced functional
recovery; and 3) increased fibrosis without affecting I/R-in-
duced angiogenesis at day 14 of reperfusion. The observation
that the doubling of acute I/R injury at day 1 translates directly
into a doubling of the number of regenerating fibers and a
doubling of fibrosis at day 14 indicates that HKII mainly
affects the acute I/R intervention and not the subsequent
regeneration capacity of skeletal muscle.
HKII and Acute I/R Cell Damage
We observed 40% injured GM fibers following 90 min
ischemia and 24 h reperfusion, values that fall within the
Fig. 6. Functional recovery of GM after ischemia and 14 days reperfusion.
Twitch (A) and tetanus (B) recovery shown as ratio of I/R to CON GM values.
C: muscle fatigue as tested by applying 30 repetitive tetani. Developed force
at each tetanus for both CON and I/R GM was measured and shown as ratio
to first tetanus of same group. Values are given as means  SE. #P  0.05 vs.
CON group of same genotype.
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reported range of 30–60% GM injury following 90–120 min
ischemia and 24 h reperfusion (5, 26, 39). In a previous study
in skeletal muscle, we showed that noninjurious I/R for WT
muscle became mildly injurious with reductions in HKII (32).
The present work underscores the importance of HKII in
injurious I/R of skeletal muscle. In heart, we recently showed
that upon 25% reduction of cardiac HKII, I/R injury was
increased by 60% (38). In the present study, skeletal muscle
HKII content was decreased by 40% (34), and I/R injury was
increased by 109%. Even though obtained in different tissues,
these results imply that the amount of HKII is inversely related
to the degree of I/R injury and therefore emphasize the impor-
tance of HKII protein levels in relation to acute skeletal muscle
cell survival.
In the past, mitochondrially bound HK was found to be the
key factor in reducing apoptosis through inhibition of the
mitochondrial permeability transition pore (mPTP) opening.
The proposed mechanism was that HK prevented proapoptotic
Bax binding to the mitochondrion by direct competition for the
same mitochondrial binding site (29). However, the importance
of Bax in the process of I/R damage and thereby HKII cellular
protection is under debate since Majewski et al. (24) showed
that HKII protection was found with and without Bax present.
Very recently, we did not find Bax-mediated apoptotic path-
way to be involved in mitochondrial HKII dissociation-medi-
ated I/R injury in the intact heart (33). The present results
support our previous work and that of Majewski et al. (24) in
that mitochondrial Bax is probably not the mediator through
which reductions in total cellular HKII result in increased I/R
cell death in muscle. Moreover, our results clearly indicate that
HKII content mainly affects the necrotic pathway of cell death
in a model of in vivo skeletal muscle I/R. No changes in
apoptotic cells or caspase activity were observed with reduced
skeletal muscle HKII content. It should be realized that ne-
crotic and apoptotic pathways of cell death are not completely
separate entities; they are often interconnected (22). Although
not directly examined in the present study, it is possible that the
decreased caspase activity in the I/R muscle of WT mice at 1
h reperfusion is a consequence of disruption of the plasma
membrane ( necrosis) and therefore leakage of the caspase
protein out of the myocyte. This could be one example as to
how necrosis may affect the apoptotic machinery. In addition,
increases in oxidative stress have also been proposed to medi-
ate the increased I/R-induced cell death with decreases in
mitochondrial HK (9, 28). In our experimental model, I/R was
indeed associated with increases in oxidative stress in WT
animals. Surprisingly, this increase in oxidative stress was
significantly attenuated in the HKII/ mice, making it un-
likely that increases in oxidative stress may explain the in-
creased cell death with chronic decreases in HKII. We previ-
ously demonstrated that mitochondrial HKII is needed to keep
mitochondria polarized (33). It is possible that in the HKIII/
Fig. 7. Muscle regeneration after ischemia followed by
14 days reperfusion. Cell plasma membranes were
stained by laminin (green) and nuclei were stained by
DAPI (blue). A: representative pictures of CON and I/R
GM tissue of WT and HKII/ animals with both stain-
ings shown in each image. Mature myocytes are recog-
nized by nuclei at the border of each cell and polygonal
shape, while immature myocytes are recognized by nu-
clei in the center of the cell, the rounded shape, and
smaller size. B: average cell size was measured in both
CON and I/R GM. C: the number of cells with central-
ized nuclei relative to the total number of cells was
counted in GM of WT and HKII/ animals. Values are
given as means  SE. *P  0.05 vs. corresponding WT
group. #P  0.01 vs. CON group of same genotype.
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mice, the reduction in mitochondrial HKII results in an in-
creased number of depolarized mitochondria, normally occur-
ring during I/R (23), which is directly translated into increased
I/R damage.
Alternatively, alterations in glycogen turnover during I/R may
also partly explain the increased injury, although the amount of
glycogen in relation to I/R damage is often a double-edged sword
as shown by Cross et al. (8). High glycogen may protect against
damage as long as it is not depleted. With lasting ischemia and
consequently full depletion of initial high glycogen, a high gly-
cogen actually may result in increased I/R damage. Our results
clearly indicate that the observed increase in necrosis with re-
ductions in HKII cannot be explained by alterations in glycogen
turnover.
Although further experiments are needed to elucidate the
mechanism through which chronic reductions in HKII exacer-
bate skeletal muscle I/R-induced myocyte necrosis, the present
work discards a possible role for glycogen turnover or apopto-
sis in explaining increased injury with reductions in HKII in a
model of in vivo skeletal muscle I/R.
HKII and Skeletal Muscle Recovery After I/R
The present study clearly demonstrates reduced functional
recovery and increased fibrosis in skeletal muscle of HKII/
mice at 14 days recovery following I/R injury. This observa-
tion can be explained by 1) a HKII-related deficiency in muscle
regeneration following I/R injury, and/or 2) a greater suscep-
tibility of HKII/ mice to the initial damage of I/R. In
general, HKII is increased in highly proliferating, growing
tissues (25) to support the increase in biosynthetic activity in
such tissues. Our observations that HKII is increased in regen-
erating I/R muscles and that skeletal muscle cell size in control
muscle is smaller in the HKII/ mice are commensurate with
this role of HKII in growth and proliferation. However, the
finding of an increased number of regenerating muscle fibers in
the GM of HKII/ mice compared with WT mice suggests
that reductions in HKII do not result in reduced regeneration.
The similar weight of the reperfused GM muscle for both WT
and HKII/ mice at 14 days recovery also indicates that
muscle regeneration is not reduced by reductions in HKII.
Actually, the observation that the doubling in the number of
Fig. 9. Fibrosis in skeletal muscle after ischemia followed by 14 days
reperfusion. A: representative pictures (A) showing Sirius red staining for
collagen (red) and muscle tissue (pink) of CON and I/R GM tissue of WT and
HKII/ animals. B: total area of collagen was normalized to the total area of
cells in each image for I/R and CON GM of WT and HKII/ animals. Values
are given as means  SE. #P  0.01 vs. CON group of same genotype. $P 
0.05 for interaction effect (I/R treatment effect in WT vs. that in HKII/).
Fig. 8. Angiogenesis in skeletal muscle after ischemia followed by 14 days
reperfusion. Capillaries were visualized by CD31 staining (pink) and plasma
membranes were stained by laminin (blue). A: representative pictures of CON
and I/R GM tissue of WT and HKII/ animals with both stainings shown in
each image. B: number of capillaries was measured and normalized to the total
area of cells in each image in CON and I/R GM of WT and HKII/ animals.
Values are given as means  SE. #P  0.01 vs. CON group of same genotype.
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regenerating fibers in HKII/ muscle at 14 days recovery
mirrors the doubling in number of death of fibers in HKII/
muscle at 1 day reperfusion indicates that the regeneration
process is not directly affected by HKII. Our data therefore
suggest that the reduced recovery of GM in HKII/ mice is
mainly a result of a greater susceptibility of HKII/ mice to
the initial damage of the I/R insult, and not to a deficiency
in muscle regeneration. The increased fibrosis with reduc-
tions in HKII also probably reflects the increased initial I/R
damage in these mice and is in agreement with the increased
cardiac fibrosis observed using the same mouse model
following an in vivo cardiac I/R insult (38).
The increase in capillary density at 14 days recovery is
similar to previous findings of increased capillarization follow-
ing I/R in skeletal muscle (18, 35). That the I/R-induced
increase in capillary density was similar for HKII/ and WT
muscle indicates that HKII does not affect I/R-induced angio-
genesis. In a previous study using the same mouse model, we
observed decreased capillary density in the border zone of the
I/R-subjected heart, and the decrease was exacerbated in the
HKII/ mice (38). However, this discrepancy is very likely
caused by the fact that the heart has very limited regenerating
capacity, such that the decreased capillary density observed for
the reperfused heart is mainly a consequence of cell death and
fibrosis in the border zone, which were both increased for
HKII/ mice compared with WT mice.
Functional recovery. The tetanic force deficit following 14
days recovery is approximately 35% for WT mice and 70% for
HKII/ mice, again mirroring the initial damage observed in
each genotype (cell death of 36% and 76% for WT and
HKII/ mice, respectively). This corroborates our morpho-
logical analyses in that the decreased functional recovery in the
HKII/ mice is probably mostly the result of the increased
initial damage and not of a slower rate of recovery during the
14 days of healing. Because the force measurements are
normalized to muscle mass, the diminished force production in
the reperfused muscles indicates that the regenerating, centro-
nucleated fibers are still in the immature state after 14 days of
recovery and not yet fully integrated as functional muscle
units.
The increase in fatigue resistance measured after I/R corre-
lates with other reports (2, 37) and possibly reflects a transition
of muscle fiber type from fast-twitch to slow oxidative fibers
(2, 36). GM muscle predominantly consists of fast-twitch fibers
(4), which are relatively prone to fatigue (36). The proposed
change to a more fatigue-resistant fiber type due to I/R would
therefore reduce fatigue vulnerability. Besides a switch in fiber
type, increased fatigue resistance may also be explained by the
I/R-induced increase in HK activity, as observed in the present
study. Fueger and colleagues have shown in different studies
that the HKII protein content is a determinant of endurance
capacity (15). Additionally, during exercise muscle glucose
uptake is reduced in HKII-reduced animals (13), while the
glucose transporter GLUT4 is unaffected by HKII reduction
(14), making glucose phosphorylation a limiting factor for
muscle glucose uptake (12, 13). Therefore, glucose phosphor-
ylation by HK is a limiting factor for muscle endurance and
fatigue properties, and the increase in HK activity observed in
the reperfused muscles of both genotypes may partly explain
the increased fatigue resistance.
In summary, our results demonstrate that reduced HKII protein
content results in impaired muscle functionality at 14 day recov-
ery following an I/R episode. The impaired recovery seems to be
mainly a result of a greater susceptibility of HKII/ mice to
I/R-induced acute necrosis (not apoptosis) and is not related to a
HKII-related deficiency in muscle regeneration. The data suggest
that manipulation of HKII protein content before I/R interventions
may be a promising avenue for preventing muscle dysfunction
following I/R.
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